These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19780743)

  • 21. Introduction of the dilation and evacuation procedure for second-trimester abortion in Vietnam using manual vacuum aspiration and buccal misoprostol.
    Castleman LD; Oanh KT; Hyman AG; Thuy le T; Blumenthal PD
    Contraception; 2006 Sep; 74(3):272-6. PubMed ID: 16904423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two routes of administration for misoprostol in the treatment of incomplete abortion: a randomized clinical trial.
    Diop A; Raghavan S; Rakotovao JP; Comendant R; Blumenthal PD; Winikoff B
    Contraception; 2009 Jun; 79(6):456-62. PubMed ID: 19442782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy.
    Tang OS; Lau WN; Chan CC; Ho PC
    BJOG; 2004 Sep; 111(9):1001-5. PubMed ID: 15327617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Misoprostol for treatment of incomplete abortion at the regional hospital level: results from Tanzania.
    Shwekerela B; Kalumuna R; Kipingili R; Mashaka N; Westheimer E; Clark W; Winikoff B
    BJOG; 2007 Nov; 114(11):1363-7. PubMed ID: 17803714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Good results of early medicinal pregnancy termination in a general practice on Curaçao].
    Boersma AA; Meyboom-de Jong B
    Ned Tijdschr Geneeskd; 2008 Mar; 152(9):504-8. PubMed ID: 18389885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregnancy termination using vaginal misoprostol in women with more than one caesarean section.
    Daponte A; Nzewenga G; Dimopoulos KD; Guidozzi F
    J Obstet Gynaecol; 2007 Aug; 27(6):597-600. PubMed ID: 17896259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sublingual versus vaginal route of misoprostol for cervical ripening prior to surgical termination of first trimester abortions.
    Saxena P; Salhan S; Sarda N
    Eur J Obstet Gynecol Reprod Biol; 2006 Mar; 125(1):109-13. PubMed ID: 16139942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of different preoperative sublingual misoprostol regimens for surgical termination of first trimester pregnancies: a prospective randomized trial.
    Ercan CM; Coksuer H; Karasahin KE; Alanbay I; Aydogan U; Parlak A; Baser I
    J Reprod Med; 2011; 56(5-6):247-53. PubMed ID: 21682121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases.
    Goh SE; Thong KJ
    Contraception; 2006 May; 73(5):516-9. PubMed ID: 16627037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sublingual misoprostol 100 microgram versus 200 microgram for second trimester abortion: a randomised trial.
    Caliskan E; Doger E; Cakiroglu Y; Corakci A; Yucesoy I
    Eur J Contracept Reprod Health Care; 2009 Feb; 14(1):55-60. PubMed ID: 19241302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized prospective study of misoprostol or mifepristone followed by misoprostol when needed for the treatment of women with early pregnancy failure.
    Stockheim D; Machtinger R; Wiser A; Dulitzky M; Soriano D; Goldenberg M; Schiff E; Seidman DS
    Fertil Steril; 2006 Oct; 86(4):956-60. PubMed ID: 17027362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of four perioperative misoprostol regimens for surgical termination of first-trimester pregnancy.
    Chambers DG; Mulligan EC; Laver AR; Weller BK; Baird JK; Herbert WY
    Int J Gynaecol Obstet; 2009 Dec; 107(3):211-5. PubMed ID: 19747679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of oral and vaginal misoprostol for cervical ripening before manual vacuum aspiration of first trimester pregnancy under local anesthesia: a randomized placebo-controlled study.
    Cakir L; Dilbaz B; Caliskan E; Dede FS; Dilbaz S; Haberal A
    Contraception; 2005 May; 71(5):337-42. PubMed ID: 15854633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A viable alternative to surgical vacuum aspiration: repeated doses of intravaginal misoprostol over 9 hours for medical termination of pregnancies up to eight weeks.
    Singh K; Fong YF; Dong F
    BJOG; 2003 Feb; 110(2):175-80. PubMed ID: 12618162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of a single misoprostol regimen in the first and second trimester termination of pregnancy.
    van Bogaert LJ; Sedibe TM
    J Obstet Gynaecol; 2007 Jul; 27(5):510-2. PubMed ID: 17701803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are two doses of misoprostol after mifepristone for early abortion better than one?
    Coyaji K; Krishna U; Ambardekar S; Bracken H; Raote V; Mandlekar A; Winikoff B
    BJOG; 2007 Mar; 114(3):271-8. PubMed ID: 17217359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation.
    Akoury HA; Hannah ME; Chitayat D; Thomas M; Winsor E; Ferris LE; Einarson TR; Seaward PG; Ryan G; Willan AR; Windrim R
    Am J Obstet Gynecol; 2004 Mar; 190(3):755-62. PubMed ID: 15042010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of vaginal misoprostol 800 microg versus 400 microg for anembryonic pregnancy: a randomized comparative trial.
    Srikhao N; Tannirandorn Y
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S41-7. PubMed ID: 17722316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study].
    Verhulsdonk MT; Papatsonis DN; Heydanus R
    Ned Tijdschr Geneeskd; 2007 Apr; 151(14):815-20. PubMed ID: 17469323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serious adverse events associated with the use of misoprostol alone for cervical preparation prior to early second trimester abortions (12-16 weeks).
    Nucatola D; Saulsberry V; Gatter M; Roth N
    Contraception; 2009 Feb; 79(2):158. PubMed ID: 19135576
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.